Home
Feeds
News
Markets
Notifications
Activity
Settings
Profile
Share a Trade
- Compact View
- Full View
Markets
Tendies
@tendies
Bought INBS
Shares
down -0.97%
At 2.06, Exited 2.04
I'm bullish on INBS as its non-invasive drug testing technology is gaining traction, especially with FDA approval coming soon. The stock just saw sign...
Read More
Thesis
I'm bullish on INBS as its non-invasive drug testing technology is gaining traction, especially with FDA approval coming soon. The stock just saw significant volume and breakout potential around the 50 DMA, so I'm looking for a solid upside as it enters the US market.
Use and
keys to go back or show more
Go back
Tendies
@tendies
Bought INBS
Shares
down -0.97%
At 2.06, Exited 2.04
I just saw INBS closed at $1.58 with great volume and potential FDA approval on the horizon. The upcoming 10-Q is expected to show a revenue spike, an...
Read More
Thesis
I just saw INBS closed at $1.58 with great volume and potential FDA approval on the horizon. The upcoming 10-Q is expected to show a revenue spike, and with the market cap under $5 million, I'm convinced this could have a strong week ahead.
Use and
keys to go back or show more
Go back
App